Doxycycline add-on therapy for lung improvement in tuberculosis
Treatments studied
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This Phase 3 trial tests whether adding doxycycline to standard TB medicine can improve lung function and reduce lung tissue damage. It aims to see if patients recover better by targeting the lung response to TB.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 21 years old or older
- Have confirmed active pulmonary TB, with positive test results (smear, NAAT, or culture)
- Start TB treatment within the past 14 days, or be about to start standard TB treatment
- Chest X-ray must show lung involvement with one or more cavities
- Be able to sign informed consent
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
This study tests whether adding the cholesterol drug atorvastatin to standard TB treatment helps people recover faster. It is for people with newly diagnosed, drug-sensitive tuberculosis who have not yet started treatment.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This study tests whether two medicines, metformin and N-acetylcysteine, can help your lungs heal better after tuberculosis (TB). You will receive one of these study drugs along with your regular TB treatment.
This trial tests whether the antibiotic doxycycline can prevent lung scarring (fibrosis) after a serious TB infection. You may be eligible if you are currently being treated for active TB and have significant lung damage on your chest X-ray.
This trial tests whether adding the antibiotic doxycycline to standard treatment can improve recovery in patients with tuberculosis of the brain (TB meningitis). It may help reduce brain swelling and damage.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.